This compound is a chemical compound used as a pharmaceutical intermediate. It features a thiazole ring substituted with chloromethyl, methyl, and trifluoromethylphenyl groups, contributing to its structural properties for further chemical synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 317318-97-1
Adrenaline EP Impurity E HCl
pharmaceutical reference impurity
2-methyl-4-[(2-methylbenzoyl)amino]Benzoic acid
Tolvaptan intermediate
(1,1'-Biphenyl)-4-carboxylic acid, (3aR,4S,5R,6aS)-hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta(b)furan-5-yl ester
Pharmaceutical intermediate for prostaglandin synthesis
Tert-Butyl (2-aminocyclohexyl)carbamate
Pharmaceutical intermediate for synthesis
Febuxostat impurity 7
Pharmaceutical impurity reference standard
Febuxostat
active pharmaceutical ingredient
5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester
Pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
Pharmaceutical intermediate for thiazole derivatives
5-(chloromethyl)-4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole
JQVJAQPUFIIRJP-UHFFFAOYSA-N
CC1=C(SC(=N1)C2=CC=C(C=C2)C(F)(F)F)CCl
—